Latest fatty liver Stories
Hispanics develop alcoholic liver disease (ALD), a common cause of liver-disease death, between four and 12 years earlier than Whites/Caucasians or African Americans, according to a new study
TEL AVIV, Israel, Feb. 25, 2015 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
DALLAS, February 1, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Non Alcoholic Fatty Liver Disease (NAFLD) Global Pipeline and Clinical Trials Review, H1, 2015 research
SOUTH SAN FRANCISCO, Calif., Jan.
Dignity Sciences today announced positive results with its anti-fibrotic compound DS102 in preclinical studies which assessed its potential effectiveness for the treatment of non-alcoholic steatohepatitis
Introducing FibroScan®: A New FDA-registered Medical Device to measure Liver Fibrosis.
PERTH, Australia, Nov.
TEL AVIV, Israel, Nov. 5, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
Argon Medical Expands its Comprehensive Biopsy Portfolio with the Addition of the TLAB® Transjugular Liver Biopsy Instrument PLANO, Texas, Sept.
- A young chicken: also used as a pet name for children.